- ES
- EN
Biomedicina
Doctoral student: Alejandro Fernández Llorente
Research Centre or Institution : Centro de Biología Molecular Severo Ochoa. CSIC - UAM
Thesis adviser: Alejandro Fernández Llorente
The lab's research aims to optimise the anti-cancer properties of the oncolytic parvovirus Minute Virus of Mice (MVM). Recent data from the lab demonstrate the ability of MVM to infect glioblastoma stem cells (Gil-Ranedo et al., Cell Reports 2021), or the use of sialic acid as a receptor in glioblastoma cells (Tania-Calvo et al., Frontiers Microbiology, 2024). In a logical progression from these contributions, the project proposed here addresses key steps of MVM entry into the cell, from contacts with the sialic receptor on the cell surface, to trafficking of the incoming particle through the endosome, and its subsequent invasion of the nucleus to initiate infection. To analyse the molecular mechanisms involved, the following objectives are proposed:
Objective 1 . Analysis of the endocytic pathway followed by the virus in human glioblastoma cells (1st-2nd year). We will analyse the interaction with the sialic receptor and the subsequent endosomal trafficking of the viral particle by comparing wild-type MVM with selected mouse mutants that have alterations in capsid residues that interact with sialic acid. Analyses will be carried out with all three viruses in human transformed cells including glioblastoma:
Objective 2 . Entry of MVM parvovirus into the nucleus of human cancer cells (2nd-3rd year). The incoming viral particle has to pass through the nuclear pore complex (NPC). To We will study:
Objective 3 . Effect of cell cycle and cell transformation on viral entry into the nucleus (3rd-4th year). Cell physiology determines the efficacy of Parvovirus infection at many levels. This study will focus on:
Activities related
Projects related
News related
Publications related
Thesis related
Conference Fotones: Herramienta de Frontera para el Avance Científico, Tecnológico, Médico e Industrial Madrid, Thursday, 21 September 2023, 19:00 hours
Session VII International ALS meeting in Spain: 30 years learning about ALS: new scenarios and challenges Madrid, Wednesday, 4 October 2023, 16:00 hours
Jornada Científica Online Investigación y avances en antivirales Online, Tuesday, 24 October 2023, 19:00 hours